Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—Rather a Bystander Than a Driver of Mortality - Concepedia

Concepedia

Publication | Open Access

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—Rather a Bystander Than a Driver of Mortality

DOI Full Paper Access

42

Citations

9

References

2021

Year

Georg Semmler, Sarah Wernly, Sebastian Bachmayer, Isabella Leitner, Bernhard Wernly, Matthias Egger, Lena Schwenoha, Leonora Datz, Lorenz Balcar, Marie Semmler,

The Journal of Clinical Endocrinology & Metabolism

Abstract

Presence of MAFLD does not increase mortality in a cohort of individuals aged 45 to 80 years.

References

	Year	Citations

Page 1